Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.

To claim your copy free of charge simply follow this link.

David Mowry Biography and Net Worth

Director of Alphatec

David H. Mowry has served as a member of the Board of Directors since February 2017. Mr. Mowry currently serves as the Chief Executive Officer of Cutera, Inc., a leading provider of energy-based aesthetic systems for physicians and other qualified practitioners worldwide. Prior to joining Cutera in July 2019, Mr. Mowry served as President, Chief Executive Officer and a director of Vyaire Medical, a recognized global leader in the respiratory diagnostics, ventilation, and anesthesia delivery and patient monitoring market segments, a position he held since May 2016. From October 2015 to May 2016 he served as Executive Vice President and Chief Operating Officer and member of the board of directors of Wright Medical Group N.V. (Nasdaq: WMGI), a global medical device company focused on extremities and biologics products, and during this time period he was also a member of the board of directors of EndoChoice Holdings, Inc. , a company focused on the manufacturing and commercialization of platform technologies relating to the treatment of gastrointestinal conditions. Prior to Wright Medical Group, Mr. Mowry served as President and Chief Executive Officer and member of the board of directors of Tornier N.V. from February 2013 until October 2015, at which time Tornier and Wright Medical Group merged, and prior to that, as Chief Operating Officer of Tornier from 2011 to 2013. Prior to this, Mr. Mowry held executive leadership positions at Covidien plc, ev3, Inc. and Zimmer Spine, Inc. Mr. Mowry received a B.S. in Engineering from the United States Military Academy at West Point.

What is David H. Mowry's net worth?: The estimated net worth of David H. Mowry is at least $917,343.33 as of September 11th, 2023. Mr. Mowry owns 92,381 shares of Alphatec stock worth more than $917,343 as of November 21st. This net worth estimate does not reflect any other assets that Mr. Mowry may own. Learn More about David H. Mowry's net worth.
How do I contact David H. Mowry?: The corporate mailing address for Mr. Mowry and other Alphatec executives is 5818 EL CAMINO REAL, CARLSBAD CA, 92008. Alphatec can also be reached via phone at (760) 431-9286 and via email at [email protected]. Learn More on David H. Mowry's contact information.
Has David H. Mowry been buying or selling shares of Alphatec?: David H. Mowry has not been actively trading shares of Alphatec over the course of the past ninety days. Most recently, David H. Mowry sold 9,500 shares of the business's stock in a transaction on Monday, September 11th. The shares were sold at an average price of $14.46, for a transaction totalling $137,370.00. Following the completion of the sale, the director now directly owns 92,381 shares of the company's stock, valued at $1,335,829.26. Learn More on David H. Mowry's trading history.
Who are Alphatec's active insiders?: Alphatec's insider roster includes Evan Bakst (Director), Jeffrey Black (CFO), Jason Hochberg (Director), Craig Hunsaker (EVP), Scott Lish (SVP), Patrick Miles (CEO), David Mowry (Director), David Pelizzon (Director), Jennifer Pritzker (Major Shareholder), Paul Segal (Major Shareholder), David Sponsel (EVP), and James Tullis (Director). Learn More on Alphatec's active insiders.
Are insiders buying or selling shares of Alphatec?: In the last twelve months, Alphatec insiders bought shares 3 times. They purchased a total of 85,000 shares worth more than $743,050.00. In the last twelve months, insiders at the medical technology company sold shares 12 times. They sold a total of 340,301 shares worth more than $4,593,019.43. The most recent insider tranaction occured on August, 21st when Director David M Demski bought 50,000 shares worth more than $283,500.00. Insiders at Alphatec own 22.8% of the company. Learn More about insider trades at Alphatec.
Information on this page was last updated on 8/21/2024.

David H. Mowry Insider Trading History at Alphatec

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/11/2023	Sell	9,500	$14.46	$137,370.00	92,381
8/29/2022	Sell	4,370	$7.85	$34,304.50	91,973
11/16/2021	Sell	14,254	$12.25	$174,611.50

David H. Mowry Buying and Selling Activity at Alphatec

Alphatec Company Overview

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.

Today's Range

Now: $9.93

$9.54

$10.12

50 Day Range

MA: $6.52

$4.98

$9.93

2 Week Range

Now: $9.93

$4.88

$17.34

Volume

2,331,810 shs

Average Volume

1,965,051 shs

Market Capitalization

$1.41 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.31

Download Our Tesla Ebook For Free

From DTI | Ad